Lista de obras -

A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis.

artículo científico publicado en 2006

A rhesus macaque model of Asian-lineage Zika virus infection

artículo científico publicado en 2016

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth

scientific article published on 20 January 2020

Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques

article

Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity

scientific article published on 31 August 2016

An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum

artículo científico publicado en 2011

An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.

artículo científico publicado en 2014

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors

artículo científico publicado en 2011

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines

artículo científico publicado en 2010

Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved

artículo científico publicado en 2014

Antibody polyspecificity and neutralization of HIV-1: a hypothesis

artículo científico publicado en 2005

Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses

artículo científico publicado en 2016

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family

artículo científico publicado en 2012

Antigen-specific B cell detection reagents: use and quality control

artículo científico publicado en 2008

B cell responses to HIV-1 infection and vaccination: pathways to preventing infection

artículo científico publicado en 2010

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.

artículo científico publicado en 2017

Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency

artículo científico publicado en 2020

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

artículo científico publicado en 2011

CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies

artículo científico publicado en 2014

Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity

artículo científico publicado en 2014

Clonal analysis of human anti-V3 monoclonal antibodies selected by a V3 tetramer ⬇️

artículo científico publicado el 1 de enero de 2012

Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk

artículo científico publicado en 2016

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies

artículo científico publicado en 2014

Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies

Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies

artículo científico publicado en 2011

Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells

artículo científico publicado en 2015

Eliminating antibody polyreactivity through addition of N-linked glycosylation

artículo científico publicado en 2015

Enhanced antibody responses to an HIV-1 membrane-proximal external region antigen in mice reconstituted with cultured lymphocytes

artículo científico publicado en 2014

Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses

artículo científico publicado en 2013

Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

artículo científico publicado en 2021

Functional interrogation and mining of natively paired human VH:VL antibody repertoires

artículo científico publicado en 2018

Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region

artículo científico publicado en 2009

H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination

artículo científico publicado en 2011

HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques

artículo científico publicado en 2017

HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions

scientific article published on 30 January 2020

HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.

artículo científico publicado en 2016

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

artículo científico publicado en 2015

HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design

artículo científico publicado en 2012

HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria

artículo científico publicado en 2014

HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection

artículo científico publicado en 2009

HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages

artículo científico publicado en 2012

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.

artículo científico publicado en 2013

HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis

artículo científico publicado en 2018

HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities

artículo científico publicado en 2014

HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities

artículo científico publicado en 2014

HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers

scientific article published on 15 July 2019

Heterologous protection against Asian Zika virus challenge in rhesus macaques

artículo científico publicado en 2016

Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection

artículo científico publicado en 2007

Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements

artículo científico publicado en 2014

Immune checkpoint modulation enhances HIV-1 antibody induction

artículo científico publicado en 2020

Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies

artículo científico publicado en 2016

Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice

artículo científico publicado en 2016

Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site.

artículo científico publicado en 2015

Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies

artículo científico publicado en 2014

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.

artículo científico publicado en 2017

Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome

artículo científico publicado en 2012

Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020

artículo científico publicado en 2020

Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.

artículo científico publicado en 2003

Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design

artículo científico publicado en 2008

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses

artículo científico publicado en 2014

Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees

artículo científico publicado en 2013

Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier

article

Influence of HLA-C expression level on HIV control

artículo científico publicado en 2013

Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses

artículo científico publicado en 2017

Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain

artículo científico publicado en 2016

Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated

artículo científico publicado en 2011

Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations ⬇️

artículo científico publicado en 2017

Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages

scientific article published on April 2016

Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum

artículo científico publicado en 2012

Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting

artículo científico publicado en 2011

Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual

artículo científico publicado en 2011

Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage

artículo científico publicado en 2015

Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs

artículo científico publicado en 2014

Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

scientific article published on 12 March 2019

Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants

artículo científico publicado en 2015

Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials

artículo científico publicado en 2012

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission

artículo científico publicado en 2015

Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.

artículo científico publicado en 2017

Modulation of HIV-1 immunity by adjuvants

artículo científico publicado en 2014

Necrotizing fasciitis caused by Haemophilus influenzae type E in a 17-year-old girl with systemic lupus erythematosus

artículo científico publicado en 2010

Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters?

artículo científico publicado en 2006

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

artículo científico publicado en 2018

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

artículo científico publicado en 2017

Polychromatic plots: graphical display of multidimensional data

artículo científico publicado en 2008

Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection

artículo científico publicado en 2009

Potent and broad HIV-neutralizing antibodies in memory B cells and plasma

artículo científico publicado en 2017

Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody

artículo científico publicado en 2012

Primary infection by a human immunodeficiency virus with atypical coreceptor tropism ⬇️

artículo científico

Progress in HIV-1 vaccine development.

artículo científico publicado en 2014

Rapid Diagnostic Tests for Malaria Parasites ⬇️

artículo científico publicado el 1 de enero de 2002

Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth

scientific article published on 19 November 2020

Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial

artículo científico publicado en 2020

Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation

artículo científico publicado en 2014

Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies

artículo científico publicado en 2011

Simultaneous Detection of Antigen-Specific IgG- and IgM-Secreting Cells with a B Cell Fluorospot Assay

artículo científico

Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.

artículo científico publicado en 2017

Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses

artículo científico publicado en 2015

Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site

artículo científico publicado en 2015

Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates

artículo científico publicado en 2021

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s

artículo científico publicado en 2022

T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response

artículo científico publicado en 2017

The Impact of Poxvirus Vector Priming, Protein Co-Administration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques

artículo científico publicado en 2017

The humoral response to HIV-1: new insights, renewed focus.

artículo científico publicado en 2010

Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques

artículo científico publicado en 2016

Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates

artículo científico publicado en 2017

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

artículo científico publicado en 2013

Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models

artículo científico publicado en 2017

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.

artículo científico publicado en 2013

Viral receptor-binding site antibodies with diverse germline origins

artículo científico publicado en 2015

Lista de obras de

A comparison of neonatal Gram-negative rod and Gram-positive cocci meningitis.

A rhesus macaque model of Asian-lineage Zika virus infection

Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth

Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques

Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity

An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum

An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines

Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved

Antibody polyspecificity and neutralization of HIV-1: a hypothesis

Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family

Antigen-specific B cell detection reagents: use and quality control

B cell responses to HIV-1 infection and vaccination: pathways to preventing infection

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.

Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies

Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity

Clonal analysis of human anti-V3 monoclonal antibodies selected by a V3 tetramer ⬇️

Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies

Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies

Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies

Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells

Eliminating antibody polyreactivity through addition of N-linked glycosylation

Enhanced antibody responses to an HIV-1 membrane-proximal external region antigen in mice reconstituted with cultured lymphocytes

Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses

Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

Functional interrogation and mining of natively paired human VH:VL antibody repertoires

Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region

H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination

HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques

HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions

HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design

HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria

HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection

HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.

HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis

HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities

HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities

HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers

Heterologous protection against Asian Zika virus challenge in rhesus macaques

Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection

Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements

Immune checkpoint modulation enhances HIV-1 antibody induction

Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies

Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice

Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site.

Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.

Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome

Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020

Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria.

Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses

Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees

Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier

Influence of HLA-C expression level on HIV control

Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses

Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain

Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated

Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations ⬇️

Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages

Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum

Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting

Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual

Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage

Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs

Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants

Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission

Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.

Modulation of HIV-1 immunity by adjuvants